Robert Steven Conlan

17PUBLICATIONS
44CO-AUTHORS
Molecular targetsSurface water quality processes and contaminated sediment assessmentPredictive and prognostic markersPharmacogenomicsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 27, 2026
Distinct H3K27 Methylation States Drive Cellular Responses to the Histone Demethylase Inhibitor GSK-J4 in Ovarian Cancer Cells.

|Mar 07, 2026
Distinct H3K27 methylation states drive cellular responses to the histone demethylase inhibitor GSK-J4 in ovarian cancer cells.

Marcos Quintela, Lydia C Powell, Agne Baseviciene

|Aug 28, 2025
Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells.

Tasmia Tahsin, Darius K McPhail, Jesse D Champion

|Dec 08, 2023
Intracellular Fate of Sub-Toxic Concentration of Functionalized Selenium Nanoparticles in Aggressive Prostate Cancer Cells.

Caroline Bissardon, Olivier Proux, Salvatore Andrea Gazze

|Oct 24, 2023
Elucidating Novel Targets for Ovarian Cancer Antibody-Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity.

Emenike Kenechi Onyido, David James, Jezabel Garcia-Parra

|Apr 29, 2023
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.

Marcos Quintela, David W James, Jetzabel Garcia

Pageof 3

Frequent Collaborators

7 joint publications

Deyarina Gonzalez

3 joint publications

Lewis W Francis

3 joint publications

Marcos Quintela

3 joint publications

David Howard